Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

GPS collars 'can monitor response to treatment'
Collie Max with GPS collar
Edinburgh vets hope to use GPS collars in future to learn more about how physical activity affects disease.

Vets study the effect of medication on dogs with osteoathritis

GPS technology could be used by vets to monitor the effects of certain medications. In a recent study, Edinburgh vets used GPS collars to determine the effects of painkillers in dogs with osteoarthritis.

Using the technology, vets from the Royal (Dick) School of Veterinary Studies were able to compare the movements of healthy dogs, to those of dogs with osteoarthritis.

According to their findings, published in the journal PLOS One, dogs treated with the anti-inflammatory painkiller Carprofen could run in nearly the same way as healthy dogs.

Lead researcher Dr Dylan Clements, said: "GPS collars have given us an insight into the levels of physical performance dogs exhibit during their normal daily activities, and show us how much we can alter a dog’s performance by keeping them on or off a lead, or playing with them.
 
"We found that they were a sensitive way for us to measure how well dogs recover from a disease that affects activity, such as osteoarthritis. We hope to be able to use the collars to understand more about how activity might contribute to or help prevent diseases in the future."

The collars allowed vets to monitor how quickly the dogs moved and changed speed, as well as how far they travelled during their normal exercise regime.

According to data collected from the collars, the dogs with osteoarthritis were able to run as quickly as healthy dogs, but their condition significantly affected their ability to speed up and slow down.

When they were treated with Carprofen, however, their performance improved to a level comparable to that of the healthy dogs for most of the measures taken during the study.

To view the research, visit: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117094
 

Image © Dr Stephen Ellwood, Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'